Drug R&D For Global Diseases Needs Revenue Incentives – BIO Meeting
Executive Summary
Development of vaccines for diseases prevalent in the developing world would be most effectively promoted by revenue-enhancing incentives, speakers at a Biotechnology Industry Association/Bill & Melinda Gates Foundation forum said